Home
HelpTest ID FMIRT Mirtazapine (Remeron)
Method Name
High Performance Liquid Chromatography with Fluorescence Detection (HPLC-FL)
Reporting Name
Mirtazapine (Remeron), SerumSpecimen Type
VariesSpecimen Required
Submit only 1 of the following specimens:
Plasma
Draw blood in a green-top (sodium heparin) tube(s), plasma gel tube is not acceptable. Spin down and send 2 mL sodium heparin plasma refrigerated in a plastic vial.
Serum
Draw blood in a plain red-top tube(s), serum gel tube is not acceptable. Spin down and send 2 mL of serum refrigerated in a plastic vial.
Specimen Minimum Volume
0.3 mL
Specimen Stability Information
| Specimen Type | Temperature | Time | Special Container |
|---|---|---|---|
| Varies | Refrigerated (preferred) | 14 days | |
| Frozen | 180 days | ||
| Ambient | 72 hours |
Reference Values
Reference range: 4.0 – 40.0 ng/mL
Expected steady state trough mirtazapine concentrations in patients receiving recommended daily dosages: 4.0 – 40.0 ng/mL
Toxic range not established.
Day(s) Performed
Monday through Sunday
Performing Laboratory
Medtox Laboratories, Inc.CPT Code Information
80335
LOINC Code Information
| Test ID | Test Order Name | Order LOINC Value |
|---|---|---|
| FMIRT | Mirtazapine (Remeron), Serum | 17283-3 |
| Result ID | Test Result Name | Result LOINC Value |
|---|---|---|
| Z3323 | Mirtazapine | 17283-3 |